Back
Xylem Vs. Keros Therapeutics Industry Stock Comparison
Buy
52
XYL
Xylem
Last Price:
129.40
Seasonality Move:
2.68%
Sell
45
KROS
Keros Therapeutics
Last Price:
64.62
Seasonality Move:
-23.47%
Buy
52
Xylem (XYL)
is a Buy
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $127.90. The Score for XYL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- XYL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $66.12. The Score for KROS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $66.12
The current trend is moderately bearish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.
XYL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.69 | Buy |
Relative Strength Index (14 RSI): | 58.29 | Buy |
Chaikin Money Flow: | 34677 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.58 | Buy |
Relative Strength Index (14 RSI): | 53.33 | Buy |
Chaikin Money Flow: | -35466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
XYL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.35 | Sell |
20-day SMA: | 127.62 | Buy |
50-day SMA: | 122.03 | Buy |
200-day SMA: | 107.86 | Buy |
8-day EMA: | 128.25 | Sell |
20-day EMA: | 127.15 | Buy |
50-day EMA: | 122.56 | Buy |
200-day EMA: | 110.79 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.19 | Sell |
20-day SMA: | 67.12 | Sell |
50-day SMA: | 60.96 | Buy |
200-day SMA: | 42.08 | Buy |
8-day EMA: | 66.4 | Sell |
20-day EMA: | 65.67 | Buy |
50-day EMA: | 60.23 | Buy |
200-day EMA: | 47.27 | Buy |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.39 per share, and an increase next year of $0.52 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Xylem Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |